0001104659-21-128649.txt : 20211021
0001104659-21-128649.hdr.sgml : 20211021
20211021205226
ACCESSION NUMBER: 0001104659-21-128649
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211021
FILED AS OF DATE: 20211021
DATE AS OF CHANGE: 20211021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLACKSON TIMOTHY P
CENTRAL INDEX KEY: 0001242992
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 211338465
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
tm2130646-17_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2021-10-21
0
0001840233
Xilio Therapeutics, Inc.
XLO
0001242992
CLACKSON TIMOTHY P
C/O XILIO THERAPEUTICS, INC.
828 WINTER STREET, SUITE 300
WALTHAM,
MA
02451
0
0
1
0
Common Stock
20068
D
Common Stock
70888
I
The Timothy P. Clackson Irrevocable GST Trust of 2020
Stock Option (right to buy)
5.51
2022-01-15
Common Stock
7525
D
Stock Option (right to buy)
5.51
2022-01-15
Common Stock
2776
D
Stock Option (right to buy)
5.51
2022-01-15
Common Stock
5281
D
Stock Option (right to buy)
5.89
2022-01-15
Common Stock
5213
D
The option was granted on July 23, 2020 for 32,846 shares. On May 21, 2019, 25% of the shares underlying the option vested and the remaining shares shall vest in equal monthly installments until May 21, 2022.
The option was granted on July 23, 2020 for 11,104 shares. On June 14, 2020, 25% of the shares underlying the option vested and the remainder shall vest in equal monthly installments thereafter until June 14, 2023.
The option was granted on July 23, 2020 for 23,045 shares. The shares began vesting on March 12, 2020 and shall vest in equal monthly installments until February 12, 2024.
The option was granted on March 11, 2021 for 35,752 shares. The shares underlying the option began vesting on April 1, 2021 and shall vest in equal monthly installments thereafter until March 1, 2025.
/s/ Timothy Clackson
2021-10-21